Patent ID: 11926874
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Measurement (Instruments)
Classification: CPC C  A  G | IPC C  G

Claim 6:
7. A method for treating a subject afflicted with a head, neck, or lung cancer, wherein cancer cells from the subject have been determined to express the soluble PD-L1 protein consisting of the amino acid sequence of SEQ ID NO: 13 by assaying a sample of the cancer cells from the subject for the presence of the soluble PD-L1 protein consisting of the amino acid sequence of SEQ ID NO: 13, the method comprising administering to the subject an anti-PD-L1 antibody agent that blocks the interaction between PD-L1 and PD-1 such that the head, neck, or lung cancer is treated.